DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4537c1/schizophrenia_pi) has announced the addition of Global Markets Direct's new report "Schizophrenia - Pipeline Review, Q4 2010" to their offering.
Schizophrenia - Pipeline Review, Q4 2010
Summary
Schizophrenia Pipeline Review, Q4 2010, provides an overview of the Schizophrenia therapeutic pipeline. This report provides information on the therapeutic development for Schizophrenia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Schizophrenia. Schizophrenia-Pipeline Review 2010, Q4 2010 is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources
Scope
- A snapshot of the global therapeutic scenario for Schizophrenia.
- A review of the Schizophrenia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Schizophrenia pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Key Topics Covered:
- List of Tables
- List of Figures
- Introduction
- Global Markets Direct Report Coverage
- Schizophrenia Overview
- Therapeutics Development
- An Overview of Pipeline Products for Schizophrenia
- Schizophrenia Therapeutics under Development by Companies
- Schizophrenia Therapeutics under Investigation by Universities/Institutes
- Late Stage Products
- Comparative Analysis
- Mid Clinical Stage Products
- Comparative Analysis
- Early Clinical Stage Products
- Comparative Analysis
- Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Companies Involved in Schizophrenia Therapeutics Development
For more information visit http://www.researchandmarkets.com/research/4537c1/schizophrenia_pi